BIZTRAC BETA
Retail sale of pharmaceutical products

HOLMLIA APOTEK AS

Org. no. 816121612 Limited company (AS) Oslo Incorporated 2015 Active
Ownership graph ↗
Revenue 2025 NOK 22.8m
Operating profit NOK 386,000
Equity NOK 275,000
Incorporated 2015
Employees 20
Share capital NOK 30,000

HOLMLIA APOTEK AS is registered as a limited company in Oslo, Oslo with organisation number 816121612. The business is classified under retail sale of pharmaceutical products (NACE 47.730). The company was incorporated in 2015 and has 20 registered employees. Registered share capital is NOK 30,000, divided into 1000 shares. The company's stated purpose is: “Eie og drive apotek, herunder konsulenttjenester innenfor apotekerbransjen og lege- og helserelaterte produkter, samt øvrig virksomhet i tilknytning til dette.”. The most recent filed accounts, for the 2025 financial year, show NOK 22.8m in revenue and NOK 386,000 in operating profit.

Key figures · 2025

Revenue
NOK 22.8m
Operating profit
NOK 386,000
Equity
NOK 275,000
Est. value
NOK 1.7m

Financial health · 2025

Liquidity
1.07
Satisfactory
Current assets ÷ current liabilities
Profitability
Not available
Return on total assets
Solidity
7.7%
Weak
Equity as a share of total capital

Who owns HOLMLIA APOTEK AS?

BÅRD ANDERSEN
HOLMLIA APOTEK AS
NOK 22.8m rev. · NOK 386,000 profit

HOLMLIA APOTEK AS has 2 registered shareholders:

All shareholders and roles →

Frequently asked questions about HOLMLIA APOTEK AS

Who owns HOLMLIA APOTEK AS?

BÅRD ANDERSEN is the largest registered owner, with 51.0%.

What is the revenue of HOLMLIA APOTEK AS?

HOLMLIA APOTEK AS had revenue of NOK 22.8m in 2025.

Who is the general manager of HOLMLIA APOTEK AS?

Hafsa Ali is registered as general manager of HOLMLIA APOTEK AS.

Where is HOLMLIA APOTEK AS based?

HOLMLIA APOTEK AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.

Report a problem

Found a technical fault, or something wrong in the data? Tell us what happened.